Pancreatic cancer 3

Common Name(s)

Pancreatic cancer 3

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Pancreatic cancer 3" for support, advocacy or research.

Logo
Pancreatic Cancer Action Network

The Pancreatic Cancer Action Network is a nationwide network of people dedicated to working together to advance research, support patients and create hope for those affected by pancreatic cancer.

Last Updated: 20 Feb 2013

View Details

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Pancreatic cancer 3" for support, advocacy or research.

Logo
Pancreatic Cancer Action Network

The Pancreatic Cancer Action Network is a nationwide network of people dedicated to working together to advance research, support patients and create hope for those affected by pancreatic cancer.

http://www.pancan.org

Last Updated: 20 Feb 2013

View Details

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Pancreatic cancer 3" returned 125 free, full-text research articles on human participants. First 3 results:

Pancreatic cancer cell-derived IGFBP-3 contributes to muscle wasting.
 

Author(s): Xiu-yan Huang, Zi-Li Huang, Ju-hong Yang, Yong-hua Xu, Jiu-Song Sun, Qi Zheng, Chunyao Wei, Wei Song, Zhou Yuan

Journal:

 

Progressive loss of skeletal muscle, termed muscle wasting, is a hallmark of cancer cachexia and contributes to weakness, reduced quality of life, as well as poor response to therapy. Previous studies have indicated that systemic host inflammatory response regarding tumor development ...

Last Updated: 15 Mar 2016

Go To URL
Nuclear translocation of fibroblast growth factor receptor 3 and its significance in pancreatic cancer.
 

Author(s): Li Zhou, Lu-Tian Yao, Zhi-Yong Liang, Wei-Xun Zhou, Lei You, Qian-Qian Shao, Shuai Huang, Jun-Chao Guo, Yu-Pei Zhao

Journal:

 

Nuclear translocation of fibroblast growth factor receptor 3 (FGFR3) was previously observed in some kinds of cancer. However, whether the phenomenon occurs in pancreatic cancer (PC), a malignancy with very dismal prognosis, remains unknown. In the present study, FGFR3 expression ...

Last Updated: 29 Jan 2016

Go To URL
A Novel Biomarker Panel Examining Response to Gemcitabine with or without Erlotinib for Pancreatic Cancer Therapy in NCIC Clinical Trials Group PA.3.
 

Author(s): David B Shultz, Jonathan Pai, Wayland Chiu, Kendall Ng, Madeline G Hellendag, Gregory Heestand, Daniel T Chang, Dongsheng Tu, Malcolm J Moore, Wendy R Parulekar, Albert C Koong

Journal:

 

NCIC Clinical Trials Group PA.3 was a randomized control trial that demonstrated improved overall survival (OS) in patients receiving erlotinib in addition to gemcitabine for locally advanced or metastatic pancreatic cancer. Prior to therapy, patients had plasma samples drawn for ...

Last Updated: 26 Jan 2016

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Pancreatic cancer 3" returned 9 free, full-text review articles on human participants. First 3 results:

Circulating Leptin and Risk of Pancreatic Cancer: A Pooled Analysis From 3 Cohorts.
 

Author(s): Rachael Z Stolzenberg-Solomon, Christina C Newton, Debra T Silverman, Michael Pollak, Leticia M Nogueira, Stephanie J Weinstein, Demetrius Albanes, Satu Männistö, Eric J Jacobs

Journal: Am. J. Epidemiol.. 2015 Aug;182(3):187-97.

 

Adiposity is associated with pancreatic cancer; however, the underlying mechanism(s) is uncertain. Leptin is an adipokine involved in metabolic regulation, and obese individuals have higher concentrations. We conducted a pooled, nested case-control study of cohort participants from ...

Last Updated: 29 Jul 2015

Go To URL
Curcumin and omega-3 fatty acids enhance NK cell-induced apoptosis of pancreatic cancer cells but curcumin inhibits interferon-γ production: benefits of omega-3 with curcumin against cancer.
 

Author(s): Milan Fiala

Journal:

 

STAT-3 and STAT-1 signaling have opposite effects in oncogenesis with STAT-3 acting as an oncogene and STAT-1 exerting anti-oncogenic activities through interferon-γ and interferon-α. The cytokine IL-6 promotes oncogenesis by stimulation of NFκB and STAT-3 signaling. Curcuminoids ...

Last Updated: 17 Feb 2015

Go To URL
Pathophysiological roles of Pim-3 kinase in pancreatic cancer development and progression.
 

Author(s): Ying-Yi Li, Naofumi Mukaida

Journal: World J. Gastroenterol.. 2014 Jul;20(28):9392-404.

 

Pim-3 is a member of the provirus integration site for Moloney murine leukemia virus (Pim) family proteins that exhibit serine/threonine kinase activity. Similar to the other Pim kinases (Pim-1 and Pim-2), Pim-3 is involved in many cellular processes, including cell proliferation, ...

Last Updated: 29 Jul 2014

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in Genetics Home Reference.

There are currently no related results available in GeneReviews.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov